Effect of Hemoglobin A1c Reduction or Weight Reduction on Blood Pressure in Glucagon‐Like Peptide‐1 Receptor Agonist and Sodium‐Glucose Cotransporter‐2 Inhibitor Treatment in Type 2 Diabetes Mellitus: A Meta‐Analysis

Effect of Hemoglobin A1c Reduction or Weight Reduction on Blood Pressure in Glucagon‐Like Peptide‐1 Receptor Agonist and Sodium‐Glucose Cotransporter‐2 Inhibitor Treatment in Type 2 Diabetes Mellitus: A Meta‐Analysis

Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) have shown their beneficial effects on cardiovascular outcomes and multiple cardiovascular risk factors, including hypertension. However, the mechanism of blood pressure (BP)–lower...

Descripción completa

Detalles Bibliográficos
Autores principales: Mengdie Hu, Xiaoling Cai, Wenjia Yang, Simin Zhang, Lin Nie, Linong Ji
Formato: Artículo
Lenguaje:English
Publicado: Wiley 2020-04-01
Colección:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Materias:
blood pressure
glucagon‐like peptide‐1 receptor agonists
meta‐analysis
sodium‐glucose cotransporter‐2 inhibitors
type 2 diabetes mellitus
Acceso en línea:https://www.ahajournals.org/doi/10.1161/JAHA.119.015323

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.119.015323

Ejemplares similares